In the production of monoclonal antibodies (mAbs), hybridomas are created. What crucial property makes hybridomas suitable for large-scale mAb production?
Ability to phagocytose antigens.
Short lifespan, ensuring consistent antibody quality.
Continuous cell division and antibody secretion.
Capacity to produce diverse antibody isotypes.
Related Questions
The development of biosimilars offers a cost-effective alternative to innovator biologics. Which of the following is NOT a key characteristic that biosimilars must demonstrate compared to their reference product?
Highly similar physicochemical properties
Comparable efficacy and safety profile
Identical amino acid sequence
Similar pharmacokinetics and pharmacodynamics
In gene therapy, which vector is commonly used to deliver functional genes into a patient's cells?
Bacteria
Plasmids
Modified viruses
Liposomes
Molecular diagnosis utilizes which biological molecule to detect diseases?
Carbohydrates
Lipids
Proteins
DNA/RNA
Consider the following statements about therapeutic drugs
I. The recombinant DNA technology is used for production of therapeutic drugs which are safe and effective
II. It avoid unwanted immunological responses, commonly observed with similar products isolated from non-human sources
III. About thirty recombinant therapeutics have been approved for human use in the world including India
Which of the statements given above are correct?
I and II
I and III
II and III
I, II and III
Consider the following statements about therapeutic drugs
I. The recombinant DNA technology is used for production of therapeutic drugs which are safe and effective
II. It avoid unwanted immunological responses, commonly observed with similar products isolated from non-human sources
III. About thirty recombinant therapeutics have been approved for human use in the world including India
Which of the statements given above are correct?
I and II
I and III
II and III
I, II and III
ELISA is a technique used to detect:
Specific DNA sequences
RNA transcripts
Antigens or antibodies
Gene mutations
RNA interference (RNAi) technology is used for therapeutic purposes by:
Introducing new genes into cells
Amplifying specific DNA sequences
Silencing specific genes involved in disease progression
Producing monoclonal antibodies
Which of the following techniques is NOT typically used in pharmacogenomics to identify genetic variations influencing drug response?
Single nucleotide polymorphism (SNP) analysis
Genome-wide association studies (GWAS)
Gene expression profiling
Satellite DNA profiling
What is the role of gene therapy in medicine?
Producing genetically modified crops
Creating new antibiotics
Introducing genes into a patient's cells to treat disease
Diagnosing genetic disorders
For the early diagnosis of a disease, which of the following is NOT typically used?
Amniocentesis
Ultrasound
Chorionic villus sampling (CVS)
Physical therapy
